Pompano Beach, FL, December 20, 2012 - Roma Financial Corporation(NASDAQ: ROMA) is one of the top percentage gainer and surged up 58.75% to $14.73 in the early trading hours.Bancorp Inc and Roma Financial Corp announced the signing of a definitive merger agreement. Under the terms of the merger agreement, 100% of the shares of Roma Financial will be converted into Investors Bancorp common stock. Each outstanding share of Roma Financial common stock will be converted into 0.8653 shares of Investors Bancorp common stock upon completion of the merger. The transaction is valued at $15.00 per Roma Financial common share. The aggregate merger consideration to be received by Roma Financial minority shareholders is $113.5 million.
Will ROMA Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://csrnewsdaily.com/c1/?company=ROMA
NYSE Euronext(NYSE: NYX) one of the top gainers in the morning session. The stock increased 35.38% to $32.58 on a traded volume of 3.59 million shares.According to report from Reuters, Intercontinentalexchange Inc is in talks to buy NYSE Euronext in a multibillion dollar deal. The deal could be announced as early as December 20, 2012. ICE has proposed a deal that would value NYSE at $33 per share, a 3% premium to its closing price on December 19, 2012. The transaction would be funded one-third by cash and the rest in stock.
How Should Investors Trade NYX After The Recent Momentum, Find Out Here http://csrnewsdaily.com/c1/?company=NYX
Eloqua Inc(NASDAQ: ELOQ) jumped up 31.25% to $23.52 on a traded volume of 420k shares. Oracle Corp has agreed to purchase Eloqua Incfor around $810 million.Eloqua is a maker of marketing automation software that listed on the NASDAQ in August. The Company makes software to enable businesses predicts and grow revenue by monitoring and measuring marketing and sales initiatives. The Company has over 1,000 customers including Cisco Systems Inc, Dell Inc and the Miami Heat and Sacramento Kings teams in the NBA.The Company has over 1,000 customers. The $23.50 per share offer represents a 31% premium to Eloqua's close on the NASDAQ.
Get Free Special Trend Analysis On ELOQ Here http://csrnewsdaily.com/c1/?company=ELOQ
Rite Aid Corporation(NYSE: RAD) soared 11.54% to $1.16 on a traded volume of 9.88 million shares after the Company announced third quarter results.The profit was $60.5 million or 7 cents per share compared to loss of $54.5 million or 6 cents a share in the previous year period. The revenue was $6.24 billion versus$6.31 billion in the prior year period. However, analysts expected the loss of 3 cents share on revenue of $6.2 billion. The Company expects its 2013 results to range from a loss of 3 cents per share to a profit of 5 cents per share.
Get Free Special Trend Analysis On RAD Here http://csrnewsdaily.com/c1/?company=RAD
IlluminaInc(NASDAQ: ILMN) surged up 7.10% to $55.89 on a traded volume of 3.43 million shares.The Company said that Roche Holding AG may have agreed to buy the Company at a price 48 percent higher than its original unsuccessful bid.
The genetic testing from Illumina Incand Life Technologies Corphave spurred broad changes in the development of new medicines. This research may also help farmers reduce the cost of producing milk.
Get Free Special Trend Analysis On ILMN Here http://csrnewsdaily.com/c1/?company=ILMN
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.